INTRODUCTION
This guide is designed mainly to aid clinical nurse specialists looking after patients with pelvic radiation disease (PRD) working in conjunction with a gastroenterologist. However, it might also help general practitioners and generalists in investigating and treating the gastrointestinal symptoms of patients following pelvic radiotherapy.
This guide defines best practice although not every investigation modality or treatment will be available in every trust.
Those using the guide, especially if non-medically qualified, should identify a senior gastroenterologist or other appropriately qualified and experienced professionals whom they can approach easily for advice if they are practising in an unsupervised clinic.
Practitioners should not use this guide outside the scope of their competency and must identify from whom they will seek advice about abnormal test results, which they do not fully understand before they start using the guide.
Where it is stated that 'this is an emergency', the user of this guide must discuss the issue with a suitably qualified person for immediate action.
Managing patients with PRD requires a different approach to those with other forms of bowel pathology. The guide also identifies test findings that may indicate that the underlying situation is potentially serious and that advice needs to be sought urgently.
Specific therapies are usually not listed by name but as a 'class' of potential drugs as different clinicians may have local constraints or preferences as to the medications available.
Important principles to consider when using the algorithms are ▸ Patients may have up to 22 gastrointestinal (GI) symptoms after pelvic radiotherapy simultaneously. ▸ Each symptom may have more than one cause. ▸ Symptoms must be investigated systematically, otherwise causes may be missed. ▸ Arranging all investigations at the first consultation reduces follow-up and allows directed treatment at all causes for symptoms at the earliest opportunity. ▸ Patients who have had radiotherapy need a different approach to patients who have GI symptoms for other reasons. ▸ Specialist centres only very rarely reach a new diagnosis of 'irritable bowel syndrome' in this patient group. ▸ Endoscopic or surgical intervention in tissues exposed to radiotherapy carries increased risk of serious complications.
This guide has three parts:
1. Introduction, guide to blood tests, how to use the algorithm and taking a history. 2. An algorithm detailing the individual investigation and treatment of each of the 22 symptoms identified as particularly relevant to this patient group. 3. A brief description of the diagnosis, treatment and management techniques of common conditions found in patients with PRD. ▸ Patient will need a liver ultrasound and liver screen including hepatitis B and C serology, ferritin, α feta protein, α1 antitrypsin, liver autoantibodies, total Igs, cholesterol, triglycerides.
GUIDELINE FOR BLOOD TESTS USED WITHIN THE GUIDE
Routine
Abnormal glucose level
→ If no history of diabetes: ▸ Between 7-11 mmol/L: refer to GP. ▸ >11 mmol/L and ketones in urine: this is an emergency. ▸ >11-20 mmol and no ketones in urine: discuss with supervising clinician within 24 h.
▸ >20 mmol/L and no ketones in urine: this is an emergency. If known diabetic: ▸ Do not check glucose levels. ▸ Consider checking HbA1c.
Abnormal corrected calcium level → ▸ If 2.6-2.9 mmol/L: discuss with supervising clinician within 24 h. ▸ If >3.0 mmol/L: this is an emergency.
GP, general practitioner; RBC, red blood cell; OGD, oesophago-gastroduodenoscopy.
Additional blood tests are indicated depending on the presenting GI symptoms and differential diagnoses as outlined in the algorithm. Borborygmi (A rumbling/gurgling noise produced by the movement of fluid or gas through the intestine) BAM is a defect in the enterohepatic circulation of bile acids. Two types of BAM exist: ileal dysfunction whereby the ability to absorb bile acids in the terminal ileum is impaired and secondly, hepatic overproduction that overwhelms terminal ileal absorption capacity. 1 Bile is secreted by the liver in direct response to the amount of ingested dietary fat. Patients with steatorrhoea usually require colesevelam. If dietary intervention is required, advice to reduce dietary fat intake to 20% of total calories can be useful but requires dietetic expertise, patient education and supportive literature.
Many patients with moderate/severe BAM will be deficient in trace elements and fat-soluble vitamins. These should be checked periodically and supplemented as appropriate.
EXOCRINE PANCREATIC INSUFFICIENCY
Definition EPI is the inadequate production and secretion of pancreatic enzymes and may occur after pelvic radiotherapy with para-aortic lymph node irradiation. 3 4 Diagnosis: Non-liquid stool sample for faecal elastase measurement (<200 μg FE1 per 1 g stool)-N Intolerance occurs from the inability to digest carbohydrates. Lactose, a component of milk and some other dairy products, is the intolerance most frequently recognised. It is due to lack of the enzyme lactase in the small intestine. Primary hypolactasia affects 70% of the world's population. Lactose or other disaccharide or monosaccharide malabsorption (eg, fructose) may occur de novo during cancer therapies (such as 5-FU chemotherapy or radiotherapy) due to damage to brush border enzymes and in some patients persists long term. 5 6 Diagnosis of carbohydrate intolerance:
▸ Trial of exclusion of products containing that specific carbohydrate in diet for 1 week. Patient to keep a record of symptoms before and during the exclusion. ▸ Specific carbohydrate breath test. Duodenal biopsies and assessment for the specific disaccharide or monosaccharide activity.
10-15% Mild BAM 5-10%
Moderate BAM <5% Severe BAM
Treatment:
▸ Long-term exclusion of products containing the carbohydrate in diet. ▸ Dietitian assessment to ensure diet remains balanced.
With lactose intolerance special attention should be paid to calcium intake. Other bone health risk factors should also be considered and vitamin and mineral supplementation started as appropriate.
5
PELVIC FLOOR DYSFUNCTION Definition Symptoms of pelvic floor dysfunction include urinary incontinence, bladder storage problems, altered bladder sensation, voiding and post micturition problems, anorectal symptoms, pelvic pain, sexual difficulties and pelvic organ prolapse (in females). Anorectal symptoms can include faecal incontinence, flatal incontinence, faecal urgency, straining to defecate, tenesmus, diminished rectal sensation, constipation, rectal prolapse, rectal bleeding and mucus discharge. A contributing factor is often constipation and a non-fermentable stool bulking agent such as Normacol can be helpful to restore rectal volume and is less likely to cause flatulence than other fibre supplements.
SMALL INTESTINAL BACTERIAL OVERGROWTH
Definition SIBO is the presence of excessive bacteria in the small intestine. Small bowel bacterial overgrowth occurs in 25% of patients during the acute phase of radiotherapy and is a cause of diarrhoea in up to 15% of patients after radiotherapy. ▸ There is no gold standard for diagnosing SIBO. ▸ Glucose hydrogen/methane breath testing ± duodenal (D2) aspirate via upper GI endoscopy. ▸ RBC folate and total serum bile acid levels may be elevated and vitamin B12 levels and faecal elastase may be low. ▸ 10-15% patients with negative tests still have SIBO.
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Suggested antibiotic treatment options if no growth on culture to direct treatment 7-10 days treatment with ▸ Ciprofloxacin 500 mg bd ▸ Doxycycline 200 mg day 1, 100 mg days 2-7/10 ▸ Clarithromycin 500 mg bd ▸ Metronidazole 400 mg tds ▸ Rifaximin 550 mg bd Symptoms can recur any time after antibiotics are stopped because the underlying cause of bacterial overgrowth cannot always be addressed. If symptoms return, repeat treatment with antibiotics for a few days every month or continually at the lowest effective dose may be helpful in managing symptoms long term. Some clinicians recommend rotating antibiotics, but this may not be effective if the organisms involved are not sensitive to the antibiotics used.
Treatment decisions should be individualised and consider the risks of long-term antibiotic therapy such as Clostridium difficile infection, cumulative irreversible neuropathy with metronidazole, Achilles tendon rupture with ciprofloxacin, intolerance, side effects, bacterial resistance and costs. [8] [9] [10] [11] APPENDIX: MANAGEMENT TECHNIQUES Written information is often helpful to supplement the management of specific diagnoses. If information sheets are not available locally, information sheets on the following can be obtained from Dr Andreyev's office at The Royal Marsden (+44 (0)20 7811 8216):
1. advice for those with constipation or who often need to strain 2. having a SeHCAT scan 3. having a glucose hydrogen/methane breath test 4. pancreatic insufficiency.
Specific leaflets are also available on the following treatments:
1. lactose free diet 2. managing fibre in your diet 3. taking antidiarrhoeal medication 4. taking colesevelam 5. taking loperamide 6. taking Normacol 7. treatment of radiation-induced gastrointestinal bleeding.
DIETARY FIBRE MANIPULATION
The mean UK average consumption of non-starch polysaccharides for healthy adults (aged 19-64 years) is 14.9 g/day for men and 12.8 g/day for women. 12 The current dietary recommended daily intake for fibre-18 g non-starch polysaccharides per day-is based on the effect that total dietary fibre has on stool weight. The rationale for this is that daily stool output of <100 g/day is associated with a non-starch polysaccharides intake of below 12 g/day and with an increased risk of bowel disease. In healthy populations, increasing non-starch polysaccharides intake from 13 to 18 g/day is associated with a 25% increase in stool weight. Some patients after pelvic radiotherapy cannot tolerate as much fibre as this. Reduction in soluble dietary fibre intake can be helpful when patients complain of any of the following symptoms: bloating, constipation, bowel obstruction, diarrhoea, rectal flatulence, mucus discharge and abdominal pain and may require help from a dietitian.
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BIOFEEDBACK
Biofeedback is widely regarded as a useful, noninvasive treatment in constipation, evacuatory disorders and faecal incontinence. Biofeedback is a behavioural approach to which there are no side effects and offers a non-surgical approach for patients with bowel dysfunction. It includes toileting exercises and pelvic floor exercises. 15 16 Biofeedback services are available locally around the UK.
PELVIC FLOOR EXERCISES
The pelvic floor muscles include the levator ani, the coccygeus and associated connective tissue and, if weakened, can cause several symptoms associated with pelvic floor dysfunction ( page 17). Exercises can strengthen the pelvic muscles so that they give support and are better coordinated. Pelvic floor exercises can improve problems with urinary incontinence, faecal incontinence or leakage and sexual function. 17 18 Technique:
1. Sit, stand or lie with your knees slightly apart. Tighten and pull up your bottom muscles as tightly as you can. Hold for at least 5 s and then relax for at least 10 s. Repeat at least five times. This will work on the strength of your muscles. 2. Next, pull the muscles up to about half of their maximum squeeze. See how long you can hold this for. Then relax for at least 10 s. Repeat at least five times. This will work on the endurance or staying power of your muscles and will improve their coordination. 3. Pull up the muscles as quickly and tightly as you can and then relax and then pull up again, and see how many times you can do this before you get tired. Try for at least five quick pull-ups. 4. Repeat exercises 1, 2 and 3 at least 10 times every day. 5. As the muscles get stronger, you will find that you can hold for longer than 5 s, and that you can do more pull-ups each time without the muscle getting tired. and gently-do not hold your breath as this will encourage straining. Try and stay as relaxed as possible 3. Try and brace your abdominal muscles. This is best done by putting your hands on your waist. Expand your waist and feel your hands being pushed out sideways. Concentrate on relaxing your anus to allow the stool to pass. Only push down from above once your anus is relaxed. 4. Relax very slightly for 1 s maintaining pressure but without the push. 5. Then brace outwards and push down again. 6. Repeat steps 1-5. Advise the patient to be careful to relax and use the correct technique, not to spend endless time in the toilet and not to strain-try again the next day. Excessive straining uses the wrong muscles and does not help the evacuating process.
TREATING BLEEDING TELANGIECTASIA Radiation-induced bleeding typically starts 6-12 months after radiotherapy, is at its worse 4 years after the end of radiotherapy and has disappeared by 8-10 years. 8 20-23 Preparation:
▸ Prepare the bowel as for colonoscopy with full bowel preparation. ▸ Use a gastroscope not a colonoscope. ▸ 30-35 mL of 5% formalin is usually sufficient to cover the telangiectasia. ▸ Initial instillation of saline can help assess how much formalin will be required.
▸ Please note whether the patient has any allergies to any of the constituents. 
